These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1070416)

  • 1. Dopaminergic function in Gilles de la Tourette's syndrome, Sydenham's chorea and torsion dystonia.
    Lal S; Allen J; Etienne P; Sourkes TL; Humphreys P
    Clin Neurol Neurosurg; 1976; 79(1):66-9. PubMed ID: 1070416
    [No Abstract]   [Full Text] [Related]  

  • 2. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
    Naidu S; Narasimhachari N
    Ann Neurol; 1980 Oct; 8(4):445-7. PubMed ID: 6159821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.
    Cohen DJ; Shaywitz BA; Caparulo B; Young JG; Bowers MB
    Arch Gen Psychiatry; 1978 Feb; 35(2):245-50. PubMed ID: 272137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease.
    Messiha FS; Knopp W
    Dis Nerv Syst; 1976 Aug; 37(8):470-3. PubMed ID: 1066216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gilles de la Tourette's syndrome in twins: clinical and neurochemical data.
    Goetz CG; Tanner CM
    Mov Disord; 1990; 5(2):173-5. PubMed ID: 1691443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of Gilles de la Tourette's syndrome.
    Bruun RD; Shapiro AK
    J Nerv Ment Dis; 1972 Nov; 155(5):328-34. PubMed ID: 4507722
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1977 Nov; 4(4):285-8. PubMed ID: 145893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis.
    Church AJ; Dale RC; Lees AJ; Giovannoni G; Robertson MM
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):602-7. PubMed ID: 12700302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
    Guilleminault C; Tharp BR; Cousin D
    J Neurol Sci; 1973 Apr; 18(4):435-41. PubMed ID: 4540626
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 13. On defining Sydenham's chorea: where do we draw the line?
    Murphy TK; Goodman WK; Ayoub EM; Voeller KK
    Biol Psychiatry; 2000 May; 47(10):851-7. PubMed ID: 10807957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?
    Murphy TK; Goodman WK; Fudge MW; Williams RC; Ayoub EM; Dalal M; Lewis MH; Zabriskie JB
    Am J Psychiatry; 1997 Mar; 154(3):402-7. PubMed ID: 9054790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.
    Moore DP
    J Clin Psychiatry; 1996 Sep; 57(9):407-14. PubMed ID: 9746449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain monoamines and amino acids in Gilles de la Tourette's syndrome: a preliminary study of subcortical regions.
    Anderson GM; Pollak ES; Chatterjee D; Leckman JF; Riddle MA; Cohen DJ
    Arch Gen Psychiatry; 1992 Jul; 49(7):584-6. PubMed ID: 1378261
    [No Abstract]   [Full Text] [Related]  

  • 17. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic dsyfunction in Tourette syndrome.
    Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT
    Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoglobulin therapy in Gilles de la Tourette syndrome].
    Müller N; Riedel M; Erfurth A; Möller HJ
    Nervenarzt; 1997 Nov; 68(11):914-6. PubMed ID: 9732736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.